Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zolezzi, Juan M.a | Carvajal, Francisco J.a | Ríos, Juvenal A.a | Ordenes, Danielaa | Silva-Alvarez, C.a | Godoy, Juan A.a; b | Inestrosa, Nibaldo C.a; b; *
Affiliations: [a] Centro de Envejecimiento y Regeneración (CARE), Santiago, Chile | [b] Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
Correspondence: [*] Correspondence to: Dr. Nibaldo C. Inestrosa, CARE Biomedical Center, Faculty of Biological Sciences, P. Catholic University of Chile, Alameda 340, PO Box 114-D, Santiago, Chile. Tel.: +56 2 6862722; Fax: +56 2 6862959; E-mail: ninestrosa@bio.puc.cl.
Abstract: St. John's wort has been the subject of studies focused on its therapeutic properties against several diseases, including Alzheimer's disease (AD). Amyloid β-peptide (Aβ), a critical peptide in AD, has been linked to the mitochondrial dysfunction often observed in this disease. Despite many efforts to prevent Aβ levels from increasing in AD, less has been done regarding the mitochondrial component. Therefore, we studied the effects of tetrahydrohyperforin (THH) on mitochondrial dysfunction of hippocampal neurons, challenged with Aβ oligomers (Aβo) and Aβo-AChE complexes. We show that THH prevents mitochondrial calcium overload and induces the modulation of fusion-fission events, arresting mitochondrial dysfunction. Moreover, our results suggest that the modulation of mitochondrial dynamics probably occurs through a peroxisome proliferator-activated receptor γ co-activator 1α-mediated mechanism, inducing mitochondrial fusion-fission protein expression. Our results offer further explanation for the effects observed for THH and the beneficial effects of this ethno-botanical drug in AD.
Keywords: Calcium, DRP1, FIS1, mitochondrial fusion-fission, neurodegeneration, PGC-1α
DOI: 10.3233/JAD-130173
Journal: Journal of Alzheimer's Disease, vol. 37, no. 4, pp. 735-746, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl